Multitarget Drugs: an Epigenetic Epiphany

ChemMedChem

Volumn , Issue , 2016, Pages 1227-1241

  Ganesan, A ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

cancer; dual inhibitors; epigenetics; histone deacetylases; multitarget drugs

Indexed keywords

DNA METHYLTRANSFERASE; ENZYME INHIBITOR; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE LYSINE METHYLTRANSFERASE; LIGAND; PHOSPHOTRANSFERASE INHIBITOR;

DNA HELIX; EPIGENETICS; GENE TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 84976502707     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201500394     Document Type: Review

References (99)

1. Reviews on epigenetics:
2. T. Suganuma, J. L. Workman, Annu. Rev. Biochem. 2011, 80, 473–499;
3. S. B. Rothbart, B. D. Strahl, Biochim. Biophys. Acta Gene Regul. Mech. 2014, 1839, 627–643;
4. C. Deans, K. A. Maggert, Genetics 2015, 199, 887–896;
5. R. K. McGinty, S. Tan, Chem. Rev. 2015, 115, 2255–2273;
6. G. D. Bowman, M. G. Poirier, Chem. Rev. 2015, 115, 2274–2295.
7. Reviews on epigenetic drug discovery:
8. B. Pachaiyappan, P. M. Woster, Bioorg. Med. Chem. Lett. 2014, 24, 21–32;
9. A. Finley, R. A. Copeland, Chem. Biol. 2014, 21, 1196–1210.
10. Reviews on DNMTs:
11. J. Lan, S. Hua, X. He, Y. Zhang, Acta Biochim. Biophys. Sin. 2010, 42, 243–252;
12. J. Fahy, A. Jeltsch, P. B. Arimondo, Expert Opin. Ther. Pat. 2012, 22, 1427–1442.
13. Reviews on TETs:
14. W. A. Pastor, L. Aravina, A. Rao, Nat. Rev. Mol. Cell Biol. 2013, 14, 341–356;
15. X. Lu, B. S. Zhao, C. He, Chem. Rev. 2015, 115, 2225–2239.
16. Reviews on HATs:
17. H. Yuan, R. Marmorstein, Biopolymers 2013, 99, 98–111;
18. B. M. Dancy, P. A. Cole, Chem. Rev. 2015, 115, 2225–2239.
19. Reviews on HDACs:
20. F. F. Wagner, M. Weïwer, M. C. Lewis, E. B. Holson, Neurotherapeutics 2013, 10, 589–604;
21. M. Mottamal, S. Zheng, T. L. Huang, G. Wang, Molecules 2015, 20, 3898–3941.
22. Reviews on sirtuins:
23. J. M. Villalba, F. J. Alcaín, BioFactors 2012, 38, 349–359;
24. H. Jing, H. Lin, Chem. Rev. 2015, 115, 2350–2375.
25. Review on histone acylation: H. Huang, S. Lin, B. A. Garcia, Y. Zhao, Chem. Rev. 2015, 115, 2376–2418.
26. Review on HDAC X-ray structures: C. Micelli, G. Rastelli, Drug Discovery Today 2015, 20, 718–735.
27. Reviews on KMTs:
28. C. Hui, T. Ye, Front. Chem. 2015, 3, 44;
29. H. Ü. Kaniskan, K. D. Konze, J. Jin, J. Med. Chem. 2015, 58, 1596–1629.
30. Reviews on PRMTs:
31. M. Schapira, R. F. de Freitas, Med. Chem. Commun. 2014, 5, 1779–1788;
32. J. Fuhrmann, K. W. Clancy, P. R. Thompson, Chem. Rev. 2015, 115, 5413–5461.
33. Reviews on KDMs:
34. T. Maes, E. Carceller, J. Salas, A. Ortega, C. Buesa, Curr. Opin. Pharmacol. 2015, 23, 52–60;
35. J. M. Burg, J. E. Link, B. S. Morgan, F. J. Heller, A. E. Hargrove, D. G. McCafferty, Biopolymers 2015, 104, 213–246;
36. Y. Zheng, J. Ma, Z. Wang, J. Li, B. Jiang, W. Zhou, X. Shi, X. Wang, W. Zhao, H. Liu, Med. Res. Rev. 2015, 35, 1032–1071.
37. Reviews on BRDs:
38. P. Filippakopoulos, S. Knapp, Nat. Rev. Drug Discovery 2014, 13, 337–356;
39. M. Brand, A. M. Measures, B. G. Wilson, W. A. Cortopassi, R. Alexander, M. Höss, D. S. Hewings, T. P. C. Rooney, R. S. Paton, S. J. Conway, ACS Chem. Biol. 2015, 10, 22–39.
40. R. Álvarez, L. Altucci, H. Gronemeyer, A. de Lera, Curr. Top. Med. Chem. 2011, 11, 2749–2787.
41. Reviews on kinases:
42. M. Rask-Andersen, J. Zhang, D. Fabbro, H. B. Schiöth, Trends Pharmacol. Sci. 2014, 35, 604–620;
43. O. Hantschel, ACS Chem. Biol. 2015, 10, 234–245.
44. S. Mahboobi, S. Dove, A. Sellmer, M. Winkler, E. Eichhorn, H. Pongratz, T. Ciossek, T. Baer, T. Maier, T. Beckers, J. Med. Chem. 2009, 52, 2265–2279.
45. X. Cai, H. X. Zhai, J. Wang, J. Forrester, H. Qu, L. Yin, C. J. Lai, R. Bao, C. Qian, J. Med. Chem. 2010, 53, 2000–2009.
46. T. J. Galloway, L. J. Wirth, A. D. Colevas, J. Gilbert, J. E. Bauman, N. F. Saba, D. Raben, R. Mehra, A. W. Ma, R. Atoyan, J. Wang, B. Burtness, A. Jimeno, Clin. Cancer Res. 2015, 21, 1566–1573.
47. T. Beckers, S. Mahboobi, A. Sellmer, M. Winkler, E. Eichhorn, H. Pongratz, T. Maier, T. Ciossek, T. Baer, G. Kelter, H.-H. Fiebig, M. Schmidt, Med. Chem. Commun. 2012, 3, 829–835.
48. M. Zuo, Y.-W. Zheng, S.-M. Lu, Y. Li, S.-Q. Zhang, Bioorg. Med. Chem. 2012, 20, 4405–4412.
49. X. Zhang, M. Su, Y. Chen, J. Li, W. Lu, Molecules 2013, 18, 6491–6503.
50. S. Mahboobi, A. Sellmer, M. Winkler, E. Eichhorn, H. Pongratz, T. Ciossek, T. Baer, T. Maier, T. Beckers, J. Med. Chem. 2010, 53, 8546–8555.
51. K. S. Ko, M. E. Steffey, K. R. Brandvold, M. B. Soellner, ACS Med. Chem. Lett. 2013, 4, 779–783.
52. A. P. Kozikowski, Y. Chen, T. Subhasish, N. E. Lewin, P. M. Blumberg, Z. Zhong, M. A. D′Annibale, W.-L. Wang, Y. Shen, B. Langley, ChemMedChem 2009, 4, 1095–1105.
53. X. Cai, H. Zhai, C. Lai, C. Qian, R. Bao (Curis Inc.), Int. PCT Pub. No. WO135571, 2012.
54. C. Qian, C.-J. Lai, R. Bao, D.-G. Wang, J. Wang, G.-X. Xu, R. Atoyan, H. Qu, L. Yin, M. Samson, B. Zifcak, A. W. S. Ma, S. DellaRocca, M. Borek, H.-X. Zhai, X. Cai, M. Voi, Clin. Cancer Res. 2012, 18, 4104–4113.
55. Review on mycophenolic acid: R. Bentley, Chem. Rev. 2000, 100, 3801–3826.
56. L. Chen, D. Wilson, H. N. Jayaram, K. W. Pankiewic, J. Med. Chem. 2007, 50, 6685–6691.
57. L. Chen, R. Petrelli, G. Gao, D. J. Wilson, G. T. McLean, H. N. Jayaram, Y. Y. Sham, K. W. Pankiewic, Bioorg. Med. Chem. 2010, 18, 5950–5964.
58. Review on HMG-CoA reductase inhibitors: P. A. C. McPherson, Mini-Rev. Med. Chem. 2012, 12, 1250–1260.
59. J.-B. Chen, T.-R. Chern, T.-T. Wei, C.-C. Chen, J.-H. Lin, J.-M. Fang, J. Med. Chem. 2013, 56, 3645–3655.
60. Review on PDE5 inhibitors: P. J. Wright, Int. J. Clin. Pract. 2006, 60, 967–975.
61. M. D. M. T. Cuadrado, R. F. Franco, A. M. O. Garcia, J. S. Oyarzabal, M. O. G. Rabal (University of Navarra), Int. PCT Pub No. WO131855, 2014.
62. Review on DNA targeting drugs: L. R. Hurley, Nat. Rev. Cancer 2002, 2, 188–200.
63. D. Griffith, M. P. Morgan, C. J. Marmion, Chem. Commun. 2009, 6735–6737
64. C. Liu, H. Ding, X. Li, C. P. Pallasch, L. Hong, D. Guo, Y. Chen, D. Wang, W. Wang, Y. Wang, M. T. Hemann, H. Jiang, EMBO Mol. Med. 2015, 7, 438–449.
65. W. Guerrant, V. Patil, J. C. Canzoneri, A. K. Oyelere, J. Med. Chem. 2012, 55, 1465–1477.
66. W. Guerrant, V. Patil, J. C. Canzoneri, L.-P. Yao, R. Hood, A. K. Oyelere, Bioorg. Med. Chem. Lett. 2013, 23, 3283–3287.
67. X. Zhang, B. Bao, X. Yu, L. Tong, Y. Luo, Q. Huang, M. Su, L. Sheng, J. Li, H. Zhu, B. Yang, X. Zhang, Y. Chen, W. Lu, Bioorg. Med. Chem. 2013, 21, 6981–6995.
68. C.-C. Yu, S.-L. Pan, S.-W. Chao, S.-P. Liu, J.-L. Hsu, Y.-C. Yang, T.-K. Li, W.-J. Huang, J.-H. Guh, Biochem. Pharmacol. 2014, 90, 320–330.
69. S. He, G. Dong, Z. Wang, W. Chen, Y. Huang, Z. Li, Y. Jiang, N. Liu, J. Yao, Z. Miao, W. Zhang, C. Sheng, ACS Med. Chem. Lett. 2015, 6, 239–243.
70. Review on nuclear hormones: J. T. Moore, J. N. Collins, K. H. Pearce, ChemMedChem 2006, 1, 504–523.
71. L. E. Tavera-Mendoza, T. D. Quach, B. Dabbas, J. Hudon, X. Liao, A. Palijan, J. L. Gleason, J. H. White, Proc. Natl. Acad. Sci. USA 2008, 105, 8250–8255.
72. M. Lamblin, B. Dabbas, R. Spingarn, R. Mendoza-Sanchez, T.-T. Wang, B.-S. An, D. C. Huang, R. Kremer, J. H. White, J. L. Gleason, Bioorg. Med. Chem. 2010, 18, 4119–4137.
73. J. Fischer, T.-T. Wang, D. Kaldre, N. Rochel, D. Moras, J. H. White, J. L. Gleason, Chem. Biol. 2012, 19, 963–971.
74. G.-L. Chen, L.-H. Wang, J. Wang, K. Chen, M. Zhao, Z.-Z. Sun, S. Wang, H.-L. Zheng, J.-Y. Yang, C.-F. Wu, Bioorg. Med. Chem. Lett. 2013, 23, 3891–3895.
75. H. K. Patel, M. I. Siklos, H. Abdelkarim, E. L. Mendonca, A. Vaidya, P. A. Petukhov, G. R. J. Thatcher, ChemMedChem 2014, 9, 602–613.
76. Review on tubulin targeting drugs: D. G. I. Kingston, J. Nat. Prod. 2009, 72, 507–515.
77. X. Zhang, J. Zhang, L. Tong, Y. Luo, M. Su, Y. Zang, J. Li, W. Lu, Y. Chen, Bioorg. Med. Chem. 2013, 21, 3240–3244.
78. X. Zhang, Y. Kong, J. Zhang, M. Su, Y. Zhou, Y. Zang, J. Li, Y. Chen, Y. Fang, X. Zhang, W. Lu, Eur. J. Med. Chem. 2015, 95, 127–135.
79. X. Zhang, J. Zhang, M. Su, Y. Zhou, Y. Chen, J. Li, W. Lu, RSC Adv. 2014, 4, 40444–40448.
80. Review on ERK signaling: A. A. Samatar, P. I. Poulikakos, Nat. Rev. Drug Discovery 2014, 13, 928–942.
81. Y. Ling, X. Wang, C. Wang, C. Xu, W. Zhang, Y. Zhang, Y. Zhang, ChemMedChem 2015, 10, 971–976.
82. Review on Wnt/β-catenin signaling: A. Blagodatski, D. Poteryaev, V. L. Katanaev, Mol. Cell. Ther. 2014, 2, 28.
83. J. Zhao, H. Quan, C. Xie, L. Lou, Pharmacol. Res. Perspect. 2014, 2, e00043.
84. E. Borretto, L. Lazzarato, F. Spallotta, C. Cencioni, Y. D‘Alessandra, C. Gaetano, R. Fruttero, A. Gasco, ACS Med. Chem. Lett. 2013, 4, 994–999.
85. Review on cereblon: K. M. Kortüm, Y. X. Zhu, C. X. Shi, P. Jedlowski, A. K. Stewart, Blood Rev. 2015, 29, 329–334.
86. G. E. Winter, D. L. Buckley, J. Paulk, J. M. Roberts, A. Souza, S. Dhe-Paganon, J. E. Bradner, Science 2015, 348, 1376–1381.
87. J. Lu, Y. Qian, M. Altieri, H. Dong, J. Wang, K. Raina, J. Hines, J. D. Winkler, A. P. Crew, K. Coleman, C. M. Crews, Chem. Biol. 2015, 22, 755–763.
88. Review on promiscuous compounds: J. Baell, M. J. Walters, Nature 2014, 513, 481–483.
89. A. Mai, D. Cheng, M. T. Bedford, S. Valente, A. Nebbioso, A. Perrone, G. Brosch, G. Sbardella, F. De Bellis, O. M. Miceli, L. Altucci, J. Med. Chem. 2008, 51, 2279–2290.
90. I. C. Pińa, J. T. Gautschi, G. Y. S. Wang, M. L. Sanders, F. J. Schmitz, D. France, S. Cornell-Kennon, L. C. Sambucetti, S. W. Remiszewski, L. B. Perez, K. W. Bair, P. Crews, J. Org. Chem. 2003, 68, 3866–3873.
91. R. Pereira, R. Benedetti, S. Perez-Rodríguez, A. Nebbioso, J. García-Rodríguez, V. Carafa, M. Stuhldreier, M. Conte, F. Rodríguez-Barrios, H. G. Stunnenberg, H. Gronemeyer, L. Altucci, A. R. de Lera, J. Med. Chem. 2012, 55, 9467–9491.
92. M. G. J. Baud, T. Leiser, P. Haus, S. Samlal, A. C. Wong, R. J. Wood, V. Petrucci, M. Gunaratnam, S. M. Hughes, L. Buluwela, F. Turlais, S. Neidle, F.-J. Meyer-Almes, A. J. P. White, M. J. Fuchter, J. Med. Chem. 2012, 55, 1731–1750.
93. D. Rotili, S. Tomassi, M. Conte, R. Benedetti, M. Tortorici, G. Ciossani, S. Valente, B. Marrocco, D. Labella, E. Novellino, A. Mattevi, L. Altucci, A. Tumber, C. Yapp, O. N. F. King, R. J. Hopkinson, A. Kawamura, C. J. Schofield, A. Mai, J. Med. Chem. 2014, 57, 42–55.
94. S. J. Atkinson, P. E. Soden, D. C. Angell, M. Bantscheff, C.-w. Chung, K. A. Giblin, N. Smithers, R. C. Furze, L. Gordon, G. Drewes, I. Rioja, J. Witherington, N. J. Parr, R. K. Prinjha, Med. Chem. Commun. 2014, 5, 342–351.
95. N. R. Rose, S. S. Ng, J. Mecinovic, B. M. R. Liénard, S. H. Bello, Z. Sun, M. A. McDonough, U. Oppermann, C. J. Schofield, J. Med. Chem. 2008, 51, 7053–7056.
96. K. Saijo, T. Katoh, H. Shimodaira, A. Oda, O. Takahashi, C. Ishioka, Cancer Sci. 2012, 103, 1994–2001.
97. K. Saijo, J. Imamura, K. Narita, A. Oda, H. Shimodaira, T. Katoh, C. Ishioka, Cancer Sci. 2015, 106, 208–215.
98. P. Ciceri, S. Müller, A. O'Mahony, O. Fedorov, P. Filippakopoulos, J. P. Hunt, E. A. Lasater, G. Pallares, S. Picaud, C. Wells, S. Martin, L. M. Wodicka, N. P. Shah, D. K. Treiber, S. Knapp, Nat. Chem. Biol. 2014, 10, 305–313.
99. Review on Polo-like kinase: B. T. Gjertsen, P. Schöffski, Leukemia 2015, 29, 11–19.